Every year, nearly 900,000 Americans are affected by venous thromboembolism (VTE), a condition in which blood clots form in ...
The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...
The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...
March 13 (Reuters) - A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from the same ...
What Is Cablivi, and Why Does It Matter? Cablivi (caplacizumab) is an injectable medicine used to treat a rare and serious blood condition called acquired thrombotic thrombocytopenic purpura (aTTP).
Blood cancer is one of the most dangerous in the world, but advancements in treatment are changing to landscape for patients. Read full article: Innovative treatments: The promise of bone marrow ...
Her passing underscores the urgent, preventable risk of cancer-associated blood clots — the second leading cause of death in people with cancer. Blood clots are one of the most serious and preventable ...
Every year, millions of people develop dangerous blood clots in their legs without realizing the life-threatening risk growing within their bodies. These formations, medically known as deep vein ...
Elizabeth Simms was 27 and pregnant when she was struck with a life-threatening pulmonary embolism. Her fourth pregnancy had been generally uncomplicated. Elizabeth was busy chasing her three young ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results